In addition to this, it has been suggested that impairment of the Nrf2-p62 signaling pathway leads to dysregulation of autophagy and increased sensitivity of melanocytes to oxidative stress (136), suggests that the Nrf2-p62 signaling pathway is a potential target for the treatment of vitiligo. The gene discussed is SQSTM1; the disease is vitiligo.